Search Results 51-60 of 14174 for anti-TNF drugs

1. Infliximab-abda (intravenous route) - Mayo Clinic

   If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Abatacept; Adalimumab; Adenovirus ...

2. Anti-inflammatory drugs, nonsteroidal (ophthalmic route) - Mayo Clinic

   Description. Ophthalmic anti-inflammatory medicines are used in the eye to lessen problems that can occur during or after some kinds of eye surgery.

3. Could Pain in the Finger Joints Be a Sign of Rheumatoid Arthritis? - Mayo Clinic News Network

   ... drugs (DMARDs) ... TNF-alpha inhibitors: Tumor necrosis factor (TNF)- ... Medications in this category include infliximab (Remicade) and etanercept (Enbrel).

4. Drugs and Supplements that Start with H - Mayo Clinic

   Drugs and Supplements. Search prescription and over-the-counter drugs . ... Adalimumab-fkjp (subcutaneous route). Humalog. Also known as. Insulin lispro ...

5. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

6. Infliximab-qbtx (intravenous route) - Mayo Clinic

   Infliximab-qbtx injection is used alone or together with other medicines (eg, methotrexate) to reduce the symptoms and prevent the progression of moderate-to- ...

7. Rituximab-abbs (intravenous route) - Mayo Clinic

   It helps to keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, or infliximab) did not work well. ... treatment with these ...

8. COVID-19 drugs: Are there any that work? - Mayo Clinic

   The U.S. Food and Drug Administration (FDA) authorized this treatment to prevent COVID-19 in some people with weakened immune systems. Medicines to treat COVID- ...

9. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

   A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...

10. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Participation eligibility. Participant eligibility includes age, gender, type ...